Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Björkman

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2010
Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia AS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosingS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2003
Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspectiveS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2013
Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapyS Björkman
Journal of Chromatography|May 3, 1985
Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformateS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2013
Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half-life change with age?S Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Population pharmacokinetics of recombinant factor IX: implications for dose tailoringS Björkman
British Journal of Clinical Pharmacology|November 1, 1985
Stereoselective disposition of indoprofen in surgical patientsS Björkman
Nuklearmedizin. Nuclear Medicine|July 7, 1999
Extensive chemical degradation of bleomycin during attempted labelling with 51-CrJ Areberg, S Björkman
Journal of Pharmaceutical Sciences|July 1, 1996
Influence of Escherichia coli endotoxin on the pharmacokinetics and respiratory depressant effect of alfentanil in rabbitsS Björkman, F Redke
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 13, 2010
Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia AS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2011
A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosingS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 2003
Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspectiveS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 22, 2013
Pharmacokinetics of plasma-derived and recombinant factor IX - implications for prophylaxis and on-demand therapyS Björkman
Journal of Chromatography|May 3, 1985
Determination of the enantiomers of indoprofen in blood plasma by high-performance liquid chromatography after rapid derivatization by means of ethyl chloroformateS Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 30, 2013
Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half-life change with age?S Björkman
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2013
Population pharmacokinetics of recombinant factor IX: implications for dose tailoringS Björkman
British Journal of Clinical Pharmacology|November 1, 1985
Stereoselective disposition of indoprofen in surgical patientsS Björkman
Nuklearmedizin. Nuclear Medicine|July 7, 1999
Extensive chemical degradation of bleomycin during attempted labelling with 51-CrJ Areberg, S Björkman
Journal of Pharmaceutical Sciences|July 1, 1996
Influence of Escherichia coli endotoxin on the pharmacokinetics and respiratory depressant effect of alfentanil in rabbitsS Björkman, F Redke
Pageof 10